Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Am Acad Dermatol ; 34(5 Pt 2): 892-7, 1996 May.
Article in English | MEDLINE | ID: mdl-8621823

ABSTRACT

Acanthosis nigricans is associated with many diseases, including internal malignancies, genetic disorders, and endocrine abnormalities. Insulin resistance frequently accompanies endocrine-associated acanthosis nigricans. We describe a patient with acanthosis nigricans associated with hyperandrogenism and extreme insulin resistance that spontaneously resolved after a marked decrease in insulin receptor antibodies.


Subject(s)
Acanthosis Nigricans/physiopathology , Hyperandrogenism/physiopathology , Insulin Resistance , Acanthosis Nigricans/etiology , Acanthosis Nigricans/pathology , Adolescent , Female , Humans , Hyperandrogenism/etiology , Hyperandrogenism/pathology , Remission, Spontaneous , Skin/pathology , Syndrome
2.
Am J Med Sci ; 308(3): 192-5, 1994 Sep.
Article in English | MEDLINE | ID: mdl-8074140

ABSTRACT

Cutaneous cryptococcosis usually is associated with concurrent systemic infection and actually may develop before clinical manifestations of cryptococcal meningitis become apparent. It is rare for a cryptococcal infection to be localized only to the skin. A case of cutaneous cryptococcosis is described in an immunocompromised patient who initially had a rash and a positive serum cryptococcal antigen titer, but no central nervous system involvement. The papular pustular skin lesions disappeared after 8 weeks of therapy with amphotericin B, which was stopped secondary to progressive azotemia. Less than 2 months after therapy, the skin lesions recurred, again without evidence of systemic disease. Treatment with oral fluconazole resulted in a gradual resolution of the cutaneous lesions. The pathogenesis of cryptococcosis is discussed, with emphasis on the management of cutaneous cryptococcosis.


Subject(s)
Cryptococcosis/microbiology , Cryptococcus neoformans/isolation & purification , Dermatomycoses/microbiology , Immunocompromised Host , Aged , Aged, 80 and over , Amphotericin B/adverse effects , Amphotericin B/therapeutic use , Cryptococcosis/drug therapy , Cryptococcosis/immunology , Dermatomycoses/drug therapy , Dermatomycoses/immunology , Female , Fluconazole/therapeutic use , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...